Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Annals of Surgical Oncology
Published in: Annals of Surgical Oncology 3/2021

01-03-2021 | Lymphedema | Reconstructive Oncology

Patient-Reported Outcome Measures in Lymphedema: A Systematic Review and COSMIN Analysis

Authors: Mark V. Schaverien, MB, ChB, MSc, MEd, MD, FRCS(Plast), Anaeze C. Offodile II, MD, MPH, Christopher Gibbons, PhD

Published in: Annals of Surgical Oncology | Issue 3/2021

Login to get access

Excerpt

The article entitled “Patient-Reported Outcome Measures in Lymphedema: A Systematic Review and COSMIN Analysis” by Dr. Beelen and colleagues reports outcomes of a systematic literature review guided by the PRISMA criteria of all patient-reported outcome measures (PROMs) used to assess health-related quality of life for patients with lymphedema.1 …
Literature
1.
2.
Coriddi M, Dayan J, Sobti N, Nash D, Goldberg J, Klassen A, et al. Systematic review of patient-reported outcomes following surgical treatment of lymphedema. Cancers Basel. 2020;12:565.CrossRef
3.
Pusic AL, Cemal Y, Albornoz C, Klassen A, Cano S, Sulimanoff I, et al. Quality of life among breast cancer patients with lymphedema: a systematic review of patient-reported outcome instruments and outcomes. J Cancer Surviv. 2013;7:83–92.CrossRef
4.
Cornelissen AJM, Kool M, Keuter XHA, Heuts EM, Piatkowski de Grzymala AA, van der Hulst RRWJ, Qiu SS. Quality-of-life questionnaires in breast cancer-related lymphedema patients: review of the literature. Lymphat Res Biol. 2018;16:134–9.CrossRef
5.
Wiser I, Mehrara BJ, Coriddi M, et al. Preoperative assessment of upper extremity secondary lymphedema. Cancers Basel. 2020;12:135.CrossRef
6.
Schaverien MV, Baumann DP, Selber JC, Chang EI, Hanasono MM, Chu C, et al. Building a multidisciplinary comprehensive academic lymphedema program. Plast Reconstr Surg Glob Open. 2020;8:e2670.CrossRef
7.
8.
Voineskos SH, Klassen AF, Cano SJ, Pusic AL, Gibbons CJ. Giving meaning to differences in BREAST-Q scores: minimal important difference for breast reconstruction patients. Plast Reconstr Surg. 2020;145:11–20.CrossRef
9.
Jaeschke R, Singer J, Guyatt GH. Measurement of health status: ascertaining the minimal clinically important difference. Control Clin Trials. 1989;10:407–15.CrossRef
10.
Guyatt GH, Osoba D, Wu AW, Wyrwich KW, Norman GR, Clinical Significance Consensus Meeting Group. Methods to explain the clinical significance of health status measures. Mayo Clin Proc. 2002;77:371–83.CrossRef
Metadata
Title
Patient-Reported Outcome Measures in Lymphedema: A Systematic Review and COSMIN Analysis
Authors
Mark V. Schaverien, MB, ChB, MSc, MEd, MD, FRCS(Plast)
Anaeze C. Offodile II, MD, MPH
Christopher Gibbons, PhD
Publication date
01-03-2021
Publisher
Springer International Publishing
Keyword
Lymphedema
Published in
Annals of Surgical Oncology / Issue 3/2021
Print ISSN: 1068-9265
Electronic ISSN: 1534-4681
DOI
https://doi.org/10.1245/s10434-020-09348-y

Other articles of this Issue 3/2021

Annals of Surgical Oncology 3/2021 Go to the issue

Sarcoma

Right Hepatectomy with Vascular and Biliary Reconstruction for a Portal Vein Leiomyosarcoma

ASO Author Reflections

ASO Author Reflections: Undertreatment of Pancreatic Cancer After Resection: Don’t Get Fooled by Favorable Final Pathology

ASO Author Reflections

ASO Author Reflections: Kidney Function After Retroperitoneal Sarcoma Resection with Nephrectomy

ASO Author Reflections

ASO Author Reflections: Complex Cancer Surgery Mortality After 30 Days: An Opportunity for Improvement

Pancreatic Tumors

Undertreatment of Pancreatic Cancer: Role of Surgical Pathology

Health Services Research and Global Oncology

Is it Time to Abandon 30-Day Mortality as a Quality Measure?